Qurient Co., Ltd. (KOSDAQ:115180)
South Korea · Delayed Price · Currency is KRW 20,200
-1,450 (-6.70%)
At close: Oct 22, 2026
Qurient Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7,067 | 6,983 | 9,180 | 9,032 | 8,469 | 4,886 |
Revenue Growth | -20.12% | -23.94% | 1.64% | 6.65% | 73.33% | - |
Gross Profit Gross Profit Growth | 815.58 | 929.87 | 1,351 | 1,763 | 1,782 | 885.22 |
Operating Income Operating Income Growth | -36,778 | -29,757 | -27,478 | -23,213 | -27,475 | -24,243 |
Net Income Net Income Growth | -38,409 | -30,123 | -24,111 | -21,117 | -25,457 | -22,848 |
Earnings Per Share EPS Growth | -1057.63 | -880.12 | -812.00 | -1193.08 | -1623.09 | -1517.69 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Wholesale and Retail Pharmaceutical Wholesale and Retail Growth | 7,067 | 6,983 | 9,168 | 9,032 | 7,877 | 4,686 |
Pharmaceutical Research and Development Pharmaceutical Research and Development Growth | - | - | 11.54 | - | 591.72 | 200 |
Total Total Growth | 7,067 | 6,983 | 9,180 | 9,032 | 8,469 | 4,886 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 34,792 | 50,052 | 48,165 | 42,821 | 33,099 | 51,909 |
Total Debt Total Debt Growth | 13,382 | 12,652 | 841.34 | 333.7 | 807.48 | 874.01 |
Net Cash (Debt) Net Cash Growth | 21,410 | 37,399 | 47,324 | 42,487 | 32,291 | 51,035 |
Net Cash Growth | -50.29% | -20.97% | 11.38% | 31.57% | -36.73% | -11.36% |
Net Cash Per Share Net Cash Per Share Growth | 589.56 | 1092.71 | 1589.96 | 2400.31 | 2058.81 | 3389.98 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -32,355 | -28,673 | -23,316 | -21,970 | -25,003 | -24,372 |
Capital Expenditures CapEx Growth | -56.75 | -59.89 | -19.33 | - | -12.85 | -146.64 |
Free Cash Flow Free Cash Flow Growth | -32,412 | -28,733 | -23,336 | -21,970 | -25,016 | -24,519 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 11.54% | 13.32% | 14.71% | 19.52% | 21.04% | 18.12% |
Operating Margin | -520.39% | -426.16% | -299.33% | -257.02% | -324.43% | -496.18% |
Pretax Margin | -562.68% | -447.71% | -272.30% | -246.34% | -320.22% | -488.83% |
Profit Margin | -543.47% | -431.40% | -262.65% | -233.80% | -300.61% | -467.63% |
FCF Margin | -458.61% | -411.50% | -254.21% | -243.25% | -295.40% | -501.83% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 116.36 | 169.76 | 16.67 | 10.00 | 14.18 | 67.88 |